BNP PARIBAS FINANCIAL MARKETS - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 83 filers reported holding LEAP THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$0
-100.0%
1
-99.9%
0.00%
Q4 2022$801
-99.6%
1,781
+728.4%
0.00%
Q3 2022$189,000
-99.8%
215
-99.8%
0.00%
Q2 2022$108,684,000
-68.7%
94,508
-52.4%
0.00%
Q1 2022$347,289,000
+143.9%
198,451
+351.6%
0.00%
Q4 2021$142,388,00043,9470.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 476,223$533,0000.13%
683 Capital Management, LLC 150,142$168,0000.02%
Alyeska Investment Group, L.P. 514,285$576,0000.01%
Baker Brothers Advisors 978,454$1,096,0000.01%
Quilter Plc 50,000$56,0000.00%
Schonfeld Strategic Advisors LLC 80,319$90,0000.00%
FMR LLC 660,800$740,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lionsbridge Wealth Management LLC 181$00.00%
GEODE CAPITAL MANAGEMENT, LLC 328,986$368,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders